logo
Volume 15, Issue 1 (4-2017)                   RBS 2017, 15(1): 59-66 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

نيکو گفتار م, خانعلی‌لو ر. Comparison of the Effectiveness of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy on Reducing Symptoms of Depression in Women with Multiple Sclerosis. RBS 2017; 15 (1) :59-66
URL: http://rbs.mui.ac.ir/article-1-516-en.html
Abstract:   (2359 Views)
Aim and Background: The aim of this study was to compare the efficacy of cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT) in reducing depression symptoms in patients with multiple sclerosis (MS). Methods and Materials: This experimental study was conducted with pretest-posttest design and control group. From among female patients with MS who referred to the MS Society in 2015 with depression symptoms, a sample of 45 individuals was selected. The subjects were randomly divided into 3 groups of CBT, ACT, and control (n = 15). Therapy sessions consisted of 8 sessions, each session was held for 45 minutes. Data were collected using the Beck Depression Inventory (BDI) and were analyzed using ANCOVA in SPSS software. Findings: The results showed that CBT and ACT were both effective in reducing depression symptoms in patients with MS (P < 0.001), but CBT was more effective compared to ACT. Conclusions: The results showed that CBT and ACT are effective methods of reducing depression in patients with MS. Due to the higher efficacy of CBT, it has been suggested as the preferential treatment for the reduction of depression symptoms in patients with MS.
Full-Text [PDF 702 kb]   (682 Downloads)    
Type of Study: Research | Subject: General
Received: 2020/02/8 | Accepted: 2017/04/15 | Published: 2017/04/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.